Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Mediators of Inflammation|July 15, 2015
LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic SteatohepatitisYasuka Matsunaga, Yusuke Nakatsu, Toshiaki Fukushima, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 3, 2011
Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytesMisaki Iwashita, Hideyuki Sakoda, Akifumi Kushiyama, et al.
The American Journal of Cardiology|July 25, 2006
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graftAlexandra J Lansky, Yi-ming Yang, Yosef Khan, et al.
Journal of Cardiology|June 5, 2008
Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in JapanDaizaburo Yanagi, Kazuyuki Shirai, Yosuke Takamiya, et al.
American Journal of Physiology. Cell Physiology|January 29, 2011
4F2hc stabilizes GLUT1 protein and increases glucose transport activityHaruya Ohno, Yusuke Nakatsu, Hideyuki Sakoda, et al.
Journal of Cardiology|December 24, 2010
Angiographic late lumen loss at the site of overlap of multiple Cypher™ sirolimus-eluting stents: ALSOCE studyYosuke Takamiya, Shin-ichiro Miura, Yoshihiro Tsuchiya, et al.
The Journal of Biological Chemistry|May 31, 2013
Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actionsJun Zhang, Yusuke Nakatsu, Takanori Shinjo, et al.
The American Journal of Cardiology|August 9, 2006
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)Yoshihiro Tsuchiya, Alexandra J Lansky, Ricardo A Costa, et al.
Pageof 6